Though HIV continues to be a major global public health issue, new HIV infections have fallen by 35 percent and AIDS-related deaths by 24 percent since 2000, saving nearly 7.8 million lives globally.1
Roche has been at the forefront of efforts to reliably diagnose and treat HIV infection since 1986. The cobas® family of instruments, and related assays, enable laboratories and healthcare providers to detect the most critical HIV targets quickly and accurately, while eliminating manual intervention and minimizing errors.
Groundbreaking research, innovative new drugs and powerful diagnostic technology continue to play a key role in that decline. Explore how Roche is helping to make a difference.
- World Health Organization (WHO). Fact sheet No. 360: HIV/AIDS. http://www.who.int/mediacentre/factsheets/fs360/en/. Accessed May 13, 2016.